DNA Diagnostic Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025– Increasing incidences of chronic diseases and adoption of new technologies are major factors driving the growth of Global DNA Diagnostics Market.
Global DNA Diagnostic Market is Valued at USD 14.98 Billion in 2018 and Expected to Reach USD 29.56 Billion by 2025 with a CAGR of 10.2% Over the Forecast Period.
Scope of DNA Diagnostic Market Report–
DNA diagnostics is a technology that permits medical professionals to recognize multiple diseases like, cancer, infectious diseases, and myogenic disorders and to decide the correct treatment for particular disease. The diagnostic system is beneficial for clinical as well as prenatal diagnostics. This concept has become advanced through human genome project and resulted in the disclosure of multiple disease-causing agents. Remarkable technologies which contains polymerase chain reaction (PCR), microarray technique, sequencing technique and mass spectrometry have also evolved the DNA diagnostic market and helps for sample preparation, DNA isolation and others. The revolutions in designing the product and improved technologies have induced doctors as well as researchers to switch the focus from traditional methods to personalized diagnostic methods.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=93642&RequestType=Sample
Global DNA diagnostic market report is segmented on the basis of product, technology, application, end-user and regional & country level. Based upon product, DNA diagnostic market is segmented into instruments, reagents and service & software. Based on technology, DNA diagnostic market is segmented into PCR, microarray, in-situ hybridization, sequencing technology, and mass spectrometry. Based on application, market is classified into oncology, infectious disease, myogenic disorder, clinical diagnostic confirmation, prenatal diagnostics, pre implantation diagnostics and others. End-user segment is categorized into point of care, diagnostic center, and self E testing/OTC.
The regions covered in this DNA diagnostic market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of DNA diagnostic is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Key Players for Conjunctivitis Drugs Market Report–
Some major key players for DNA diagnostics market are Sysmex Corporation, Bayer Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid Inc., Hologic Corporation, Illumina, Novartis International Ag, Thermo Fisher Scientific Inc., Bio-Rad Laboratories and others.
Roche Introduced Ventana HER2 Dual ISH DNA Probe Cocktail Assay.
on April 23rd, 2019; The Roche announced new Ventana HER2 dual ISH DNA Review blend assess to detect HER2 biomarker in breast and gastric cancer patients. HER2 stands for “Human epidermal growth factor receptor 2” and a noteworthy biomarker noticed in both breast and gastric cancers. This can be done within the same day donating clinicians with faster results related to the common methods of confirmatory testing for HER2. The results so obtained from tests can be read using light microscopy, which helps in avoiding the use of specialized fluorescence microscopes. Roche asserts that it is the only supplier of a fully automated brightfield Dual ISH solution to identify HER2 magnification. The new ventana HER2 dual ISH DNA probe blend can be completely automated on the standard IHC/ISH devices that swiftly offer vibrant results to pathology labs, qualifying to make treatment decisions prior. Currently, the assay is available in Latin America, Europe, Middle East and Africa and Asia pacific countries. Roche is preparing for the approval of US Food and Drug administration. Herceptin is a humanized monoclonal antibody that fixes particular part of the HER2 protein, limiting the signals it sends which progress tumor cell growth and also alarms body’s immunity to attack the cancer cells.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=93642&RequestType=Methodology
Global DNA Diagnostics Market Dynamics–
Increasing pervasiveness of chronic and infectious diseases, growing acceptance of personalized medicines, developing healthcare infrastructure in developing economies and most importantly raising the geriatric population fuelling the growth of this market. In addition, technological advancements followed by developing of strong methodologies like sequence technology, microarray, novel gene sequencing, myogenic disorder and others are also supplementing the market growth. Furthermore, growing priorities for systematic diagnostic staging and increasing research and development activities are some of the other major factors driving the growth of the DNA diagnostic market. However, the development process required high cost for tests followed by reciprocal involvement that gives inaccurate result and the strict regulating requirements are the issues that may hamper the market growth. Moreover, the undiscovered market in the DNA diagnostics field of the developing economies, new product launches, partnership and collaboration with medical industries and others are forming new trends in the DNA diagnostics market.
Global DNA Diagnostic Market Regional Analysis-
The DNA diagnostic market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. North America is anticipated to dominate the global DNA diagnostics market owing to the growing pervasiveness of infectious and chronic diseases and acceptance of new technologies of the DNA diagnostic testing in this region. According to WHO statistics, most frequently registered sexually transmitted infection is Chlamydia in the US with more than 1.4 million diagnosed with addition of 1.4 million people that are undiagnosed. The Government of North America is taking initiatives and provide funds for DNA testing. Asia-Pacific is anticipated to witness a significant growth in this market in upcoming years. The reasons behind the growth of Asia-Pacific region are rise in the healthcare expenditure, huge pool of untested or undiagnosed patients in the countries and increasing awareness regarding the advanced healthcare treatments in the countries such as China and India.
Key Benefits for DNA Diagnostic Market Report–
DNA diagnostic Market report covers in-depth historical and forecast analysis.
DNA diagnostic Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
DNA diagnostic Market report helps to identify opportunities in marketplace.
DNA diagnostic Market report covers extensive analysis of emerging trends and competitive landscape.
Global DNA Diagnostic Market Segmentation:
Service & Software
Hepatitis B Virus
Hepatitis C Virus
Chlamydia Trachomatic and Neisseria Gonorrhea (CT/NG)
Clinical Diagnostic Confirmation
Point of care
By Regional & Country Analysis:
Middle East and Africa
Rest of Middle East and Africa
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global DNA Diagnostics Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global DNA Diagnostics Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. DNA Diagnostics Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter – Global DNA Diagnostics Market Overview: Quantitative Analysis
4. Chapter – Global DNA Diagnostics Market Analysis: By Product Type
5. Chapter – Global DNA Diagnostics Market Analysis: By Technology
6. Chapter – Global DNA Diagnostics Market Analysis: By Application
7. Chapter – Global DNA Diagnostics Market Analysis: By End Users
8. Chapter – Global DNA Diagnostics Market Analysis: By Manufacturer
9. Chapter –DNA Diagnostics Market: Regional Analysis
10. Chapter – Company Profiles
10.1. Sysmex Corporation
10.1.3. Product portfolio
10.1.4. DNA Diagnostics Market Revenue (USD Million) and Market Share (%), 2014 – 2018
10.1.5. DNA Diagnostics Sales Market Share (%), 2014 – 2018
10.1.6. Business strategy
10.1.7. Recent developments
10.2. Bayer Corporation
10.3. Roche Diagnostics
10.4. Abbott Laboratories
10.5. Cepheid Inc
10.6. Hologic Corporation
10.8. Novartis International Ag
10.9. Thermo Fisher Scientific Inc.
10.10. Bio-Rad Laboratories
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org